Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol-Reference-Cited by-同舟云学术

Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

Published:2018-09 Issue:9 Volume:20 Page:571-575
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Garg Satish K.¹²,Peters Anne L.³,Buse John B.⁴,Danne Thomas⁵

Affiliation:

1. Department of Medicine and Pediatrics, School of Medicine, University of Colorado Denver, Aurora, Colorado.

2. Barbara Davis Center for Diabetes, Aurora, Colorado.

3. Keck School of Medicine of the University of Southern California, Los Angeles, California.

4. University of North Carolina School of Medicine, Chapel Hill, North Carolina.

5. Children's and Youth Hospital Auf der Bult, Hannover Medical School, Hannover, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2018.0246

Reference27 articles.

1. Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia

2. Hyperglycemic Crises in Adult Patients With Diabetes

3. DhatariyaK, SavageM: The management of diabetic ketoacidosis in adults. 2nd ed. Solihull, West Midlands, UK: Joint British Diabetes Societies Inpatient Care Group, 2013.

4. Centers for Disease Control and Prevention: National Diabetes Statistics Report. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services, 2017.

5. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin;Diabetes Technology & Therapeutics;2024-09-01

2. Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-related Complications;Canadian Journal of Diabetes;2024-07

3. Use of Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: The Promise and the Perils;Endocrine Practice;2024-06

4. Innovations and applications of ketone body monitoring in diabetes care;Diabetology International;2024-05-28

5. Harnessing the Synergy of SGLT2 Inhibitors and Continuous Ketone Monitoring (CKM) in Managing Heart Failure among Patients with Type 1 Diabetes;Healthcare;2024-03-29